Related Experiment Video
Updated: Nov 28, 2025

A Mouse Model to Evaluate the Long-Term Structural and Functional Outcomes after the Reversal of Prolonged Unilateral Ureteric Obstruction
Published on: July 18, 2025
Design and development of the Pediatric Urology Recovery After Surgery Endeavor (PURSUE) multicentre pilot and
Kyle O Rove1,2, Andrew C Strine3, Duncan T Wilcox4,2
1Department of Pediatric Urology, Children's Hospital Colorado, Aurora, Colorado, USA kyle.rove@childrenscolorado.org.
Insights
This study evaluates the Enhanced Recovery After Surgery (ERAS) protocol for pediatric lower urinary tract reconstruction. The goal is to reduce complications and improve surgical recovery in young patients undergoing these procedures.
Area of Science:
- Paediatric Urology
- Surgical Recovery Protocols
- Enhanced Recovery After Surgery (ERAS)
Background:
- Lower urinary tract reconstruction in children is a high-stress procedure with significant complication rates.
- Existing data suggests Enhanced Recovery After Surgery (ERAS) protocols can reduce complications in paediatric urology.
- A standardized ERAS protocol is needed for lower urinary tract reconstruction in paediatric and young adult patients.
Purpose of the Study:
- To develop and assess the feasibility of a multicentre Enhanced Recovery After Surgery (ERAS) protocol for paediatric lower urinary tract reconstruction.
- To define and measure process, patient-reported, and clinically relevant outcomes.
- To compare outcomes between ERAS protocol patients and historical controls.
Main Methods:
- A multicentre, prospective, propensity-matched, case-control study design.
- Inclusion of paediatric and adolescent/young adult patients (4-25 years) undergoing specific lower urinary tract reconstructions.
- Pilot phase to verify implementation, followed by propensity matching to historical controls for the main study.
- Outcome measures include protocol adherence, length of stay, readmissions, reoperations, ER visits, complications, pain, and opioid use.
Main Results:
- The study is designed to detect a 2-day decrease in mean length of stay.
- Pilot phase will assess protocol adherence (target ≥70%) and reasons for deviations.
- Exploratory phase will analyze ERAS protocol adherence and secondary outcomes including length of stay, readmissions, and complications.
Conclusions:
- This study will provide crucial insights into the feasibility and impact of ERAS protocols in paediatric lower urinary tract reconstruction.
- Findings will inform best practices and guide future iterations of ERAS implementation in paediatric surgical care.
- The research aims to improve patient outcomes and reduce healthcare resource utilization.
Introduction:
Lower urinary tract reconstruction in paediatric urology represents a physiologically stressful event that is associated with high complication rates, including readmissions and emergency room visits. Enhanced recovery after surgery (ERAS) protocol is a set of multidisciplinary, perioperative strategies designed to expedite surgical recovery without adversely impacting readmission or reoperation rates. Early paediatric urology data demonstrated ERAS reduced complications in this population.
Methods And Analysis:
In 2016, a working group of paediatric urologists and anaesthesiologists convened to develop an ERAS protocol suitable for patients undergoing lower urinary tract reconstruction and define study process measures, patient-reported outcomes and clinically relevant outcomes in paediatric and adolescent/young adult patients. A multicentre, prospective, propensity-matched, case-control study design was chosen. Each centre will enrol five pilot patients to verify implementation. Subsequent enrolled patients will be propensity matched to historical controls. Eligible patients must be aged 4-25 years and undergoing planned operations (bladder augmentation, continent ileovesicostomy or appendicovesicostomy, or urinary diversion). 64 ERAS patients and 128 controls will be needed to detect a decrease in mean length of stay by 2 days. Pilot phase outcomes include attainment of ≥70% mean protocol adherence per patient and reasons for protocol deviations. Exploratory phase primary outcome is ERAS protocol adherence, with secondary outcomes including length of stay, readmissions, reoperations, emergency room visits, 90-day complications, pain scores, opioid usage and differences in Quality of Recovery 9 scores.
Ethics And Dissemination:
This study has been registered with authors' respective institution review boards and will be published in peer-reviewed journals. It will provide robust insight into the feasibility of ERAS in paediatric urology, determine patient outcomes and allow for iteration of ERAS implementations as new best practices and evidence for paediatric surgical care arise. We anticipate this study will take 4 years to fully accrue with completed follow-up.
Trial Registration Number:
NCT03245242; Pre-results.
Related Concept Videos
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Urodynamic Studies: Uroflowmetry
Urologic Endoscopic Procedure: Cystoscopic Examination

